Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Synaptonemal complex protein 3 (SYCP3) is a structural protein required for the formation and stabilization of the lateral elements of the synaptonemal complex during meiosis. SYCP3 forms highly elongated, helical tetramers that bind DNA via their N-terminal regions, enabling looping and compaction of homologous chromosomes to support proper recombination and crossover formation during gametogenesis. SYCP3 self-assembles into filamentous higher-order structures along the chromosome axis, in cooperation with other synaptonemal complex constituents. It is not considered a classical drug target, but its dysregulation has been linked to infertility and cancer due to disruption of normal chromosome segregation and DNA repair pathways[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Synaptonemal complex protein 3 (SYCP3).